Alterations in erythrocyte fatty acid composition in preclinical Alzheimer’s disease
Open Access
- 6 April 2017
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 7 (1) , 1-9
Abstract
Brain and blood fatty acids (FA) are altered in Alzheimer’s disease and cognitively impaired individuals, however, FA alterations in the preclinical phase, prior to cognitive impairment have not been investigated previously. The current study therefore evaluated erythrocyte FA in cognitively normal elderly participants aged 65–90 years via trans-methylation followed by gas chromatography. The neocortical beta-amyloid load (NAL) measured via positron emission tomography (PET) using ligand 18F-Florbetaben, was employed to categorise participants as low NAL (standard uptake value ratio; SUVR < 1.35, N = 65) and high NAL or preclinical AD (SUVR ≥ 1.35, N = 35) wherein, linear models were employed to compare FA compositions between the two groups. Increased arachidonic acid (AA, p < 0.05) and decreased docosapentaenoic acid (DPA, p < 0.05) were observed in high NAL. To differentiate low from high NAL, the area under the curve (AUC) generated from a ‘base model’ comprising age, gender, APOEε4 and education (AUC = 0.794) was outperformed by base model + AA:DPA (AUC = 0.836). Our findings suggest that specific alterations in erythrocyte FA composition occur very early in the disease pathogenic trajectory, prior to cognitive impairment. As erythrocyte FA levels are reflective of tissue FA, these alterations may provide insight into the pathogenic mechanism(s) of the disease and may highlight potential early diagnostic markers and therapeutic targets.Keywords
This publication has 43 references indexed in Scilit:
- Red blood cell omega-3 fatty acid levels and markers of accelerated brain agingNeurology, 2012
- Comparative Lipidomic Analysis of Mouse and Human Brain with Alzheimer DiseaseJournal of Biological Chemistry, 2012
- Altered neuroinflammatory, arachidonic acid cascade and synaptic markers in postmortem Alzheimer’s disease brainTranslational Psychiatry, 2011
- Phospholipases A2 and Inflammatory Responses in the Central Nervous SystemNeuroMolecular Medicine, 2009
- The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's diseaseInternational Psychogeriatrics, 2009
- Phospholipase A2 reduction ameliorates cognitive deficits in a mouse model of Alzheimer's diseaseNature Neuroscience, 2008
- Imaging Neuroinflammation in Alzheimer's Disease with Radiolabeled Arachidonic Acid and PETJournal of Nuclear Medicine, 2008
- Dietary patterns and risk of dementiaNeurology, 2007
- Assessment of Memory Complaint in Age-Associated Memory Impairment: The MAC-QInternational Psychogeriatrics, 1992
- “Mini-mental state”Journal of Psychiatric Research, 1975